| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | IN BRIEF: Raspberry Pi commercial chief sells GBP250,000 in shares | ||
| Mo | DIRECTOR DEALINGS: Roadside Real Estate CEO buys after Hoch purchase | ||
| Mo | LONDON MARKET MIDDAY: FTSE 100 retreats as Middle East nerves grow | ||
| Mo | Feedback shares fall as NHS contract decision delayed | ||
| Mo | Ferrexpo extends runway with vessel sale; eyes equity raise | ||
| Mo | CAB Payments criticises Helios-led consortium for blocking StoneX bid | ||
| Mo | IN BRIEF: Impax Environmental exit tender attracts 78% of shares | ||
| Mo | WINNERS & LOSERS: Kosmos Energy climbs; Feedback hit by NHS delay | ||
| Mo | Elixirr International hails 2025 a "defining year" as profit advances | ||
| Mo | M&C Saatchi confident of meeting 2026 aims after annual profit slumps | ||
| Mo | RTW Biotech gets net asset value lift from IPO of Kailera Therapeutics | ||
| Mo | Auction Technology confirms outlook as CEO to depart after 10 years | ||
| Mo | WINNERS & LOSERS: Energy stocks rise with oil; Renishaw ups guidance | ||
| Mo | UPDATE: Evoke confirms talks for USD200 million offer from Bally's | ||
| Mo | Advanced Medical Solutions confirms bid approach from TA Associates | ||
| Mo | Kainos sees revenue ahead of consensus after second-half strength | ||
| Mo | LONDON BROKER RATINGS: Deutsche cuts Workspace; Keefe cuts NatWest | ||
| Mo | Plus500 expects sales and profit ahead of hopes amid market volatility | ||
| Mo | AstraZeneca's Tozorakimab meets primary endpoint in "pivotal" trial | ||
| Mo | LONDON MARKET OPEN: FTSE 100 falls on heightened Middle East tensions | ||
| Mo | Renishaw lifts full-year outlook as strong demand boosts order book | ||
| Mo | GSK wins China approval for Blenrep for refractory multiple myeloma | ||
| Mo | LONDON BRIEFING: Kainos guides revenue beat; Evoke in takeover talks | ||
| Mo | IN BRIEF: EPE Special Opportunities manager invests GBP2.6 million | ||
| Mo | LONDON MARKET EARLY CALL: FTSE 100 to fall as US-Iran tensions mount |